Literature DB >> 2922890

Serum-Zn-levels in prostatic cancer.

A Feustel1, R Wennrich, B Schmidt.   

Abstract

Zinc in serum of both patients with prostatic carcinoma and men without prostatic cancer was analyzed by flame atomic absorption spectrometry (FAAS). No significant differences were found between the group with prostatic carcinoma without metastasis and the group used for comparison. The Zn level in serum of patients with both prostatic carcinoma and metastases was decreased in comparison to the other groups. A decrease in the Zn concentration was also found for men without metastases after orchiectomy and hormone therapy.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2922890     DOI： 10.1007/BF00261049

Source DB:  PubMed          Journal:  Urol Res        ISSN： 0300-5623


  7 in total

1.  Zinc, cadmium and selenium concentrations in separated epithelium and stroma from prostatic tissues of different histology.

Authors:  A Feustel; R Wennrich; H Dittrich
Journal:  Urol Res       Date:  1987

2.  Plasma zinc and magnesium alterations in acute myocardial infarction.

Authors:  H Zumkley; H Vetter; H P Bertram; B Tank; W Wirth
Journal:  Klin Wochenschr       Date:  1980-10-15

3.  The zinc and copper content of blood leucocytes and plasma from patients with benign and malignant prostates.

Authors:  F K Habib; T C Dembinski; S R Stitch
Journal:  Clin Chim Acta       Date:  1980-07-01       Impact factor: 3.786

4.  Plasma zinc legels in prostatic disease.

Authors:  E G Willden; M R Robinson
Journal:  Br J Urol       Date:  1975-06

5.  Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH).

Authors:  A Feustel; R Wennrich; D Steiniger; P Klauss
Journal:  Urol Res       Date:  1982

6.  Zinc and cadmium plasma and erythrocyte levels in prostatic carcinoma, BPH, urological malignancies, and inflammations.

Authors:  A Feustel; R Wennrich
Journal:  Prostate       Date:  1986       Impact factor: 4.104

7.  Zinc and cadmium in cell fractions of prostatic cancer tissues of different histological grading in comparison to BPH and normal prostate.

Authors:  A Feustel; R Wennrich
Journal:  Urol Res       Date:  1984
  7 in total
  6 in total

1.  Zinc in the human prostate gland: normal, hyperplastic and cancerous.

Authors:  T V Sviridova; S V Zaichick
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

2.  Docetaxel-mediated apoptosis in myeloid progenitor TF-1 cells is mitigated by zinc: potential implication for prostate cancer therapy.

Authors:  Peter Makhov; Alexander Kutikov; Konstantin Golovine; Robert G Uzzo; Daniel J Canter; Vladimir M Kolenko
Journal:  Prostate       Date:  2011-02-09       Impact factor: 4.104

3.  Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappaB and reduces the malignant potential of prostate cancer cells in vitro and in vivo.

Authors:  Konstantin Golovine; Peter Makhov; Robert G Uzzo; Tavis Shaw; David Kunkle; Vladimir M Kolenko
Journal:  Clin Cancer Res       Date:  2008-09-01       Impact factor: 12.531

Review 4.  The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Shadan Ali; Aamir Ahmad; Yiwei Li; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2012-05-10

Review 5.  Comparative study of serum zinc concentrations in benign and malignant prostate disease: A Systematic Review and Meta-Analysis.

Authors:  Jiang Zhao; Qingjian Wu; Xiaoyan Hu; Xingyou Dong; Liang Wang; Qian Liu; Zhou Long; Longkun Li
Journal:  Sci Rep       Date:  2016-05-12       Impact factor: 4.379

Review 6.  Advances of Zinc Signaling Studies in Prostate Cancer.

Authors:  Dangdang Li; Daniel B Stovall; Wenmeng Wang; Guangchao Sui
Journal:  Int J Mol Sci       Date:  2020-01-19       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.